Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Services

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

157 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-21

Study Completion Date

2024-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Together with individual predisposition to form vascular clots and clinical conditions that further increase this risk, venous thromboembolism (VTE) poses a significant additional morbidity and mortality risk for the majority of the world's population. Although VTE causes serious disability and death when undiagnosed, it is a medical condition that can be prevented when diagnosed early. Although all hospitalized patients are at risk of DVT, studies have shown that 75% of hospitalized patients are hospitalized in internal clinics.As a result of this observational study, it was aimed to determine the VTE risk levels of the patients from the time of hospitalization and to determine preventive nursing care for VTE.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients

NCT04439383

Venous Thromboembolism Venous Thromboses Pulmonary Embolism +4 more

COMPLETED

Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

NCT01851239

Venous Thromboembolism

COMPLETED

Risk Prediction of Venous Thromboembolism in Critically Ill

NCT03773939

Venous Thrombosis Critical Illness

UNKNOWN

Predicting the Risk of Venous Thromboembolism in Critically Ill Patients

NCT05498142

Venous Thromboembolism Critical Illness

UNKNOWN

Prevention of Venous Thromboembolism Disease in Emergency Departments

NCT01212393

Quality of Health Care

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Venous Thromboembolism (VTE) refers to interrelated diagnoses such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). 10-20% of venous thromboembolic events occur in medical patients and 10-80% in intensive care patients. Recognized as a major complication for medical and surgical patients, VTE has been described as the 'silent killer' of hospitalized patients. During the Covid-19 pandemic in recent years, high rates of thrombolytic events have been reported in hospitalized COVID-19 patients. Nurses have an important role in identifying risk factors for VTE, taking precautions and assessing patient compliance with these precautions. The nurse should identify risk factors in the preoperative period, long-term and intensive care hospitalizations by taking a comprehensive history and physical assessment of the patient before hospitalization. There are several risk assessment models developed to assess the risk of VTE for application to inpatient medical patients. There are various risk assessment models developed for application to inpatient medical patients. Padua and IMPROVE VTE risk assessment models are frequently used. In the literature, it is stated that the Padua model gives moderate results and the IMPROVE model gives moderate-good results in predicting risk (1). Therefore, risk levels were not determined with the IMPROVE risk assessment tool in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Determination of VTE risk levels

Determination of VTE risk levels of patients using IMPROVE risk assessment tool according to deep vein thrombosis and pulmonary embolism risk factors

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be conscious,
* Consent of the patient's relatives to participate in the study in unconscious patients
* 24 hours have passed since hospitalization
* The patient admitted to hospitalization has been pre-assessed by the nurse and the pre-assessment form and nurse observation form have been completed

Exclusion Criteria

* Surgical patients
* Pregnant patients
* Refusing to participate in the study during the completion of the data collection forms.
* In unconscious patients, the patient's relatives did not give consent to participate in the study
* Unconscious patient whose relatives cannot be reached
* The patient admitted to hospitalization was not pre-assessed by the nurse and the pre-assessment form and nurse observation form were not filled out

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No